Low-Cost Infection Control Measures Show Promise in Combating Deadly Neonatal Sepsis

A new study reveals that implementing a bundle of low-cost infection prevention and control (IPC) measures can temporarily disrupt outbreaks of Klebsiella pneumoniae, a leading cause of neonatal sepsis and mortality in Africa and South Asia. While not a complete solution, the interventions offer a valuable strategy in resource-limited settings where antibiotic resistance is rising.

The Threat of Neonatal Sepsis

Sepsis, a life-threatening condition arising from the body’s response to an infection, is a major contributor to neonatal mortality in low- and middle-income countries (LMICs). Klebsiella pneumoniae (K. Pneumoniae) is a significant pathogen driving these infections, and its increasing resistance to antibiotics poses a critical challenge. Rapid and accurate diagnosis of sepsis can also be difficult in these settings.

Study Findings: A Multifaceted Approach

Researchers from Boston University School of Public Health (BUSPH) and the London School of Hygiene & Tropical Medicine (LSHTM) investigated the impact of IPC measures on a K. Pneumoniae outbreak in a Zambian neonatal intensive care unit (NICU). The findings, published in PLOS Global Public Health, demonstrated that the interventions successfully interrupted the outbreak, leading to decreased neonatal mortality, suspected sepsis cases, and confirmed bloodstream infections.

The low-cost IPC bundle included:

• IPC training for hospital staff
• Text message reminders reinforcing the training
• Onsite production of alcohol hand rub using a World Health Organization (WHO) formulation
• Enhanced cleaning protocols throughout the NICU
• Weekly bathing of babies with 2% chlorhexidine gluconate

Challenges Remain: Bacterial Re-emergence and Resistance

Despite the initial success, the study also revealed that K. Pneumoniae transmission wasn’t entirely eliminated. Some bacteria re-emerged, along with new strains, leading to further infections. Importantly, a large proportion of the bacteria tested produced extended spectrum beta-lactamases (ESBLs), enzymes that confer resistance to penicillin and other common antibiotics. A smaller number exhibited carbapenemase enzymes, indicating resistance to carbapenem antibiotics, often considered a “last resort” treatment option.

The Power of Genomic Surveillance

The researchers emphasized the value of whole genome sequencing (WGS) in understanding pathogen spread. WGS, considered the “gold standard” for bacterial identification, provided a detailed picture of the outbreak dynamics. The study found that most infections likely originated from contaminated sources within the NICU, rather than external sources. Notably, nearly 35% of K. Pneumoniae infections occurred within the first 24 to 48 hours of a baby’s admission, suggesting exposure to high doses of bacteria soon after arrival.

Future Directions: Vaccine Development and Continued IPC Efforts

Researchers are exploring the potential for a vaccine targeting K. Pneumoniae to protect newborns, particularly in high-risk regions. A meta-analysis published in PLOS Medicine suggests that a 20-strain vaccine could protect against at least 70% of K. Pneumoniae neonatal sepsis cases in Africa and South Asia.

However, in the absence of a widely available vaccine, continued IPC efforts are crucial. “These interventions are sorely needed in many areas around the world as antimicrobial resistance continues to widen,” says Dr. Davidson Hamer, professor of global health and medicine at BUSPH. He notes that countries like India and Thailand are already experiencing resistance to carbapenem antibiotics, highlighting the urgent need for preventive measures to reduce antibiotic use and leisurely the development of resistance.

Key Takeaways

• Low-cost IPC measures can temporarily disrupt outbreaks of K. Pneumoniae in neonatal intensive care units.
• Antibiotic resistance is a growing threat, making prevention strategies essential.
• Whole genome sequencing is a valuable tool for understanding pathogen spread and informing IPC efforts.
• Vaccine development offers a promising long-term solution, but continued IPC measures are crucial in the meantime.